Log in

International Biotechnology Trust (IBT.L) Share Forecast, Price & News

GBX 786
-22.00 (-2.72 %)
(As of 10/28/2020 11:00 PM ET)
Today's Range
Now: GBX 786
50-Day Range
MA: GBX 797.56
52-Week Range
Now: GBX 786
Volume124,533 shs
Average Volume89,586 shs
Market Capitalization£301.60 million
P/E RatioN/A
Dividend Yield5.32%
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Read More
International Biotechnology Trust (IBT.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars

Industry, Sector and Symbol

Industry Asset Management
Phone44 20 7421 7070



Sales & Book Value

Annual Sales£-13,271,000.00
Cash FlowGBX 3.59 per share
Book ValueGBX 623.90 per share



Market Cap£301.60 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 786
-22.00 (-2.72 %)
(As of 10/28/2020 11:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IBT News and Ratings via Email

Sign-up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

International Biotechnology Trust (IBT.L) (LON:IBT) Frequently Asked Questions

How has International Biotechnology Trust (IBT.L)'s stock price been impacted by Coronavirus?

International Biotechnology Trust (IBT.L)'s stock was trading at GBX 544 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IBT shares have increased by 44.5% and is now trading at GBX 786.
View which stocks have been most impacted by COVID-19

How often does International Biotechnology Trust (IBT.L) pay dividends? What is the dividend yield for International Biotechnology Trust (IBT.L)?

International Biotechnology Trust (IBT.L) announced a dividend on Wednesday, July 8th. Investors of record on Thursday, July 16th will be paid a dividend of GBX 12.40 per share on Friday, August 28th. This represents a dividend yield of 1.54%. The ex-dividend date of this dividend is Thursday, July 16th. The official announcement can be seen at this link.
View International Biotechnology Trust (IBT.L)'s dividend history

Who are some of International Biotechnology Trust (IBT.L)'s key competitors?

What other stocks do shareholders of International Biotechnology Trust (IBT.L) own?

Who are International Biotechnology Trust (IBT.L)'s key executives?

International Biotechnology Trust (IBT.L)'s management team includes the following people:
  • Ms. Lucy Cost Duarte, Head of Investor Relations
  • Ms. Kate Bingham, Managing Partner (Age 53)
  • Ms. Ailsa Craig, Investment Mang.
  • Dr. Carl Harald Janson, Lead Investment Mang.

What is International Biotechnology Trust (IBT.L)'s stock symbol?

International Biotechnology Trust (IBT.L) trades on the London Stock Exchange (LON) under the ticker symbol "IBT."

How do I buy shares of International Biotechnology Trust (IBT.L)?

Shares of IBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is International Biotechnology Trust (IBT.L)'s stock price today?

One share of IBT stock can currently be purchased for approximately GBX 786.

How big of a company is International Biotechnology Trust (IBT.L)?

International Biotechnology Trust (IBT.L) has a market capitalization of £301.60 million and generates £-13,271,000.00 in revenue each year.

What is International Biotechnology Trust (IBT.L)'s official website?

The official website for International Biotechnology Trust (IBT.L) is www.ibtplc.com.

How can I contact International Biotechnology Trust (IBT.L)?

International Biotechnology Trust (IBT.L)'s mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The company can be reached via phone at 44 20 7421 7070.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.